Wrinkles – Pipeline Review, H2 2012Global Markets DirectNovember 28, 2012 51 Pages - SKU: GMD4922498 |
- Introduction
- Global Markets Direct Report Coverage
- Wrinkles Overview
- Therapeutics Development
- An Overview of Pipeline Products for Wrinkles
- Wrinkles Therapeutics under Development by Companies
- Wrinkles Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Pre-Clinical Stage Products
- Comparative Analysis
- Wrinkles Therapeutics – Products under Development by Companies
- Wrinkles Therapeutics – Products under Investigation by Universities/Institutes
- Companies Involved in Wrinkles Therapeutics Development
- Allergan, Inc.
- Merz GmbH & Co. KGaA
- Revance Therapeutics, Inc.
- NovaLead Pharma Pvt. Ltd.
- Wrinkles – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- RT-001 - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- onabotulinum toxin A - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- onabotulinumtoxinA - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Autologous Fibroblast Transplantation - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- NLP-02 - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- onabotulinumtoxinA - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- FibroStem - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Wrinkles Therapeutics – Drug Profile Updates
- Wrinkles Therapeutics - Dormant Products
- Wrinkles – Product Development Milestones
- Featured News & Press Releases
- Apr 17, 2012: Fibrocell Science Announces Publication Of LAVIV Pivotal Trial Data In Dermatologic Surgery
- Apr 17, 2012: Merz Pharma Canada Announces Health Canada Approval Of XEOMIN COSMETIC
- Mar 14, 2012: Merz Aesthetics And Merz Pharma Commit To Full Remediation Compliance In Allergan Lawsuit
- Nov 07, 2011: Studies Show LAVIV Effectively Improves Appearance Of Smile Line Wrinkles
- Oct 11, 2011: Medicis Receives FDA Approval For Lip Indication For Restylane
- Oct 03, 2011: Fibrocell Science Announces Launch Of LAVIV
- Jun 22, 2011: Fibrocell Receives FDA Approval For Azficel-T
- Apr 27, 2011: FDA Panel Recommends Lip Indication for Medicis's RESTYLANE
- Mar 10, 2011: Fibrocell Science Submits Final Data From Histology Study Of Azficel-T To FDA
- Jan 12, 2011: Fibrocell Science Receives FDA Acceptance For Review Of Azficel-T Complete Response Submission
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Number of Products Under Development for Wrinkles, H2 2012
- Products under Development for Wrinkles – Comparative Analysis, H2 2012
- Number of Products under Development by Companies, H2 2012
- Number of Products under Investigation by Universities/Institutes, H2 2012
- Comparative Analysis by Late Stage Development, H2 2012
- Comparative Analysis by Mid Clinical Stage Development, H2 2012
- Comparative Analysis by Early Clinical Stage Development, H2 2012
- Comparative Analysis by Pre-Clinical Stage Development, H2 2012
- Products under Development by Companies, H2 2012
- Products under Investigation by Universities/Institutes, H2 2012
- Allergan, Inc., H2 2012
- Merz GmbH & Co. KGaA, H2 2012
- Revance Therapeutics, Inc., H2 2012
- NovaLead Pharma Pvt. Ltd., H2 2012
- Assessment by Monotherapy Products, H2 2012
- Assessment by Stage and Route of Administration, H2 2012
- Assessment by Stage and Molecule Type, H2 2012
- Wrinkles Therapeutics – Drug Profile Updates
- Wrinkles Therapeutics – Dormant Products
- List of Figures
- Number of Products under Development for Wrinkles, H2 2012
- Products under Development for Wrinkles – Comparative Analysis, H2 2012
- Products under Development by Companies, H2 2012
- Products under Investigation by Universities/Institutes, H2 2012
- Late Stage Products, H2 2012
- Mid Clinical Stage Products, H2 2012
- Early Clinical Stage Products, H2 2012
- Pre-Clinical Stage Products, H2 2012
- Assessment by Monotherapy Products, H2 2012
- Assessment by Route of Administration, H2 2012
- Assessment by Stage and Route of Administration, H2 2012
- Assessment by Molecule Type, H2 2012
- Assessment by Stage and Molecule Type, H2 2012
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Dermatology Reports